Traws Pharma
TRAW
TRAW
28 hedge funds and large institutions have $1.27M invested in Traws Pharma in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 2 closing their positions.
Holders
28
Holders Change
+4
Holders Change %
+16.67%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
5
Closed
2
Calls
$5K
Puts
–
Net Calls
+$5K
Net Calls Change
-$17K
Top Buyers
Top Sellers
1 |
1
Renaissance Technologies
New York
|
$131K |
2 |
2
Two Sigma Advisers
New York
|
$67.5K |
3 |
3
Two Sigma Investments
New York
|
$88.7K |
4 |
4
UBS Group
Zurich,
Switzerland
|
$45 |
5 |
5
Millennium Management
New York
|
$8.41K |